IBDEI0N2 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10979,0)
 ;;=V61.22^^47^611^44
 ;;^UTILITY(U,$J,358.3,10979,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10979,1,2,0)
 ;;=2^V61.22
 ;;^UTILITY(U,$J,358.3,10979,1,5,0)
 ;;=5^Perpetrator-Parental Child
 ;;^UTILITY(U,$J,358.3,10979,2)
 ;;=^304358
 ;;^UTILITY(U,$J,358.3,10980,0)
 ;;=V61.23^^47^611^40
 ;;^UTILITY(U,$J,358.3,10980,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10980,1,2,0)
 ;;=2^V61.23
 ;;^UTILITY(U,$J,358.3,10980,1,5,0)
 ;;=5^Parent-Biological Child Prob
 ;;^UTILITY(U,$J,358.3,10980,2)
 ;;=^338508
 ;;^UTILITY(U,$J,358.3,10981,0)
 ;;=V61.24^^47^611^39
 ;;^UTILITY(U,$J,358.3,10981,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10981,1,2,0)
 ;;=2^V61.24
 ;;^UTILITY(U,$J,358.3,10981,1,5,0)
 ;;=5^Parent-Adopted Child Prob
 ;;^UTILITY(U,$J,358.3,10981,2)
 ;;=^338509
 ;;^UTILITY(U,$J,358.3,10982,0)
 ;;=V61.25^^47^611^42
 ;;^UTILITY(U,$J,358.3,10982,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10982,1,2,0)
 ;;=2^V61.25
 ;;^UTILITY(U,$J,358.3,10982,1,5,0)
 ;;=5^Parent-Foster Child Prob
 ;;^UTILITY(U,$J,358.3,10982,2)
 ;;=^338510
 ;;^UTILITY(U,$J,358.3,10983,0)
 ;;=V40.31^^47^611^52
 ;;^UTILITY(U,$J,358.3,10983,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10983,1,2,0)
 ;;=2^V40.31
 ;;^UTILITY(U,$J,358.3,10983,1,5,0)
 ;;=5^Wandering-Dis Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,10983,2)
 ;;=^340621
 ;;^UTILITY(U,$J,358.3,10984,0)
 ;;=V40.39^^47^611^1
 ;;^UTILITY(U,$J,358.3,10984,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10984,1,2,0)
 ;;=2^V40.39
 ;;^UTILITY(U,$J,358.3,10984,1,5,0)
 ;;=5^Behavioral Problem NEC
 ;;^UTILITY(U,$J,358.3,10984,2)
 ;;=^340622
 ;;^UTILITY(U,$J,358.3,10985,0)
 ;;=V65.19^^47^611^45
 ;;^UTILITY(U,$J,358.3,10985,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10985,1,2,0)
 ;;=2^V65.19
 ;;^UTILITY(U,$J,358.3,10985,1,5,0)
 ;;=5^Person Consulting on Behalf of Pt
 ;;^UTILITY(U,$J,358.3,10985,2)
 ;;=^329985
 ;;^UTILITY(U,$J,358.3,10986,0)
 ;;=V66.7^^47^611^8
 ;;^UTILITY(U,$J,358.3,10986,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10986,1,2,0)
 ;;=2^V66.7
 ;;^UTILITY(U,$J,358.3,10986,1,5,0)
 ;;=5^Encounter for Palliative Care
 ;;^UTILITY(U,$J,358.3,10986,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,10987,0)
 ;;=V11.4^^47^611^20
 ;;^UTILITY(U,$J,358.3,10987,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10987,1,2,0)
 ;;=2^V11.4
 ;;^UTILITY(U,$J,358.3,10987,1,5,0)
 ;;=5^Hx Combat/Operational Stress
 ;;^UTILITY(U,$J,358.3,10987,2)
 ;;=^339674
 ;;^UTILITY(U,$J,358.3,10988,0)
 ;;=V60.1^^47^611^22
 ;;^UTILITY(U,$J,358.3,10988,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10988,1,2,0)
 ;;=2^V60.1
 ;;^UTILITY(U,$J,358.3,10988,1,5,0)
 ;;=5^Inadequate Housing
 ;;^UTILITY(U,$J,358.3,10988,2)
 ;;=^295540
 ;;^UTILITY(U,$J,358.3,10989,0)
 ;;=V62.84^^47^611^49
 ;;^UTILITY(U,$J,358.3,10989,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10989,1,2,0)
 ;;=2^V62.84
 ;;^UTILITY(U,$J,358.3,10989,1,5,0)
 ;;=5^Suicidal Ideation
 ;;^UTILITY(U,$J,358.3,10989,2)
 ;;=^332876
 ;;^UTILITY(U,$J,358.3,10990,0)
 ;;=V62.85^^47^611^18
 ;;^UTILITY(U,$J,358.3,10990,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10990,1,2,0)
 ;;=2^V62.85
 ;;^UTILITY(U,$J,358.3,10990,1,5,0)
 ;;=5^Homicidal Ideation
 ;;^UTILITY(U,$J,358.3,10990,2)
 ;;=^339690
 ;;^UTILITY(U,$J,358.3,10991,0)
 ;;=V58.61^^47^611^25
 ;;^UTILITY(U,$J,358.3,10991,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10991,1,2,0)
 ;;=2^V58.61
 ;;^UTILITY(U,$J,358.3,10991,1,5,0)
 ;;=5^L/T (Current) Anticoagulant Use
 ;;^UTILITY(U,$J,358.3,10991,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,10992,0)
 ;;=V58.62^^47^611^24
 ;;^UTILITY(U,$J,358.3,10992,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0N2
